Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab

F. Rongioletti, M. Borenstein, Robert Kirsner, Francisco Kerdel

Research output: Contribution to journalArticlepeer-review


This report describes the case of a patient with erythrodermic psoriasis who had failed all previous therapies and been hospitalized numerous times over a 12-year period that responded dramatically to treatment with infliximab. The potential utility of infliximab as a therapeutic alternative for erythrodermic psoriasis is discussed.

Original languageEnglish
Pages (from-to)222-225
Number of pages4
JournalJournal of Dermatological Treatment
Issue number4
Publication statusPublished - Dec 2003


  • Erythrodermic psoriasis
  • Etanercept
  • Infliximab
  • TNF-alpha

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Erythrodermic, recalcitrant psoriasis: Clinical resolution with infliximab'. Together they form a unique fingerprint.

Cite this